Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Inhibition of West Nile Virus Multiplication in Cell Culture by Anti-Parkinsonian Drugs.

Blázquez AB, Martín-Acebes MA, Saiz JC.

Front Microbiol. 2016 Mar 7;7:296. doi: 10.3389/fmicb.2016.00296. eCollection 2016.

2.

The composition of West Nile virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis.

Martín-Acebes MA, Merino-Ramos T, Blázquez AB, Casas J, Escribano-Romero E, Sobrino F, Saiz JC.

J Virol. 2014 Oct;88(20):12041-54. doi: 10.1128/JVI.02061-14. Epub 2014 Aug 13.

3.

[A case of central nervous system infection due to west nile virus lineage-1 in ankara province, Turkey].

Ocal M, Onder H, Arsava EM, Alp S, Ozkul A, Ergünay K.

Mikrobiyol Bul. 2013 Jan;47(1):164-72. Turkish.

4.
5.

West Nile virus: the Indian scenario.

Paramasivan R, Mishra AC, Mourya DT.

Indian J Med Res. 2003 Sep;118:101-8. Review.

PMID:
14700342
6.

Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).

Escribano-Romero E, Gamino V, Merino-Ramos T, Blázquez AB, Martín-Acebes MA, de Oya NJ, Gutiérrez-Guzmán AV, Escribano JM, Höfle U, Saiz JC.

Vaccine. 2013 Sep 23;31(41):4523-7. doi: 10.1016/j.vaccine.2013.07.071. Epub 2013 Aug 6.

PMID:
23933372
7.

West Nile Disease Epidemiology in North-West Africa: Bibliographical Review.

Benjelloun A, El Harrak M, Belkadi B.

Transbound Emerg Dis. 2016 Dec;63(6):e153-e159. doi: 10.1111/tbed.12341. Epub 2015 Mar 6. Review.

PMID:
25753775
8.

West Nile virus infection in children.

Barzon L, Pacenti M, Sinigaglia A, Berto A, Trevisan M, Palù G.

Expert Rev Anti Infect Ther. 2015;13(11):1373-86. doi: 10.1586/14787210.2015.1083859. Epub 2015 Aug 31. Review.

PMID:
26325613
9.

Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.

Desprès P, Combredet C, Frenkiel MP, Lorin C, Brahic M, Tangy F.

J Infect Dis. 2005 Jan 15;191(2):207-14. Epub 2004 Dec 10.

PMID:
15609230
10.

Expression of mosquito microRNA Aae-miR-2940-5p is downregulated in response to West Nile virus infection to restrict viral replication.

Slonchak A, Hussain M, Torres S, Asgari S, Khromykh AA.

J Virol. 2014 Aug;88(15):8457-67. doi: 10.1128/JVI.00317-14. Epub 2014 May 14.

11.

Detection of West Nile virus and tick-borne encephalitis virus in birds in Slovakia, using a universal primer set.

Csank T, Bhide K, Bencúrová E, Dolinská S, Drzewnioková P, Major P, Korytár Ľ, Bocková E, Bhide M, Pistl J.

Arch Virol. 2016 Jun;161(6):1679-83. doi: 10.1007/s00705-016-2828-5. Epub 2016 Mar 21.

PMID:
27001305
12.

Pharmacological Inhibition of Protein Kinase C Reduces West Nile Virus Replication.

Blázquez AB, Vázquez-Calvo Á, Martín-Acebes MA, Saiz JC.

Viruses. 2018 Feb 23;10(2). pii: E91. doi: 10.3390/v10020091.

13.

Antiviral Properties of the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika Virus, and Dengue Virus.

Vázquez-Calvo Á, Jiménez de Oya N, Martín-Acebes MA, Garcia-Moruno E, Saiz JC.

Front Microbiol. 2017 Jul 11;8:1314. doi: 10.3389/fmicb.2017.01314. eCollection 2017.

14.

The West Nile virus-like flavivirus Koutango is highly virulent in mice due to delayed viral clearance and the induction of a poor neutralizing antibody response.

Prow NA, Setoh YX, Biron RM, Sester DP, Kim KS, Hobson-Peters J, Hall RA, Bielefeldt-Ohmann H.

J Virol. 2014 Sep 1;88(17):9947-62. doi: 10.1128/JVI.01304-14. Epub 2014 Jun 18.

15.

Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.

Volz A, Lim S, Kaserer M, Lülf A, Marr L, Jany S, Deeg CA, Pijlman GP, Koraka P, Osterhaus AD, Martina BE, Sutter G.

Vaccine. 2016 Apr 7;34(16):1915-26. doi: 10.1016/j.vaccine.2016.02.042. Epub 2016 Mar 2.

PMID:
26939903
16.

Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain.

Beatman EL, Massey A, Shives KD, Burrack KS, Chamanian M, Morrison TE, Beckham JD.

J Virol. 2015 Dec 30;90(6):2767-82. doi: 10.1128/JVI.02949-15.

17.

Context-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus Assembly.

VanBlargan LA, Davis KA, Dowd KA, Akey DL, Smith JL, Pierson TC.

J Virol. 2015 Aug;89(16):8632-42. doi: 10.1128/JVI.01253-15. Epub 2015 Jun 10.

18.

A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.

Pinto AK, Richner JM, Poore EA, Patil PP, Amanna IJ, Slifka MK, Diamond MS.

J Virol. 2013 Feb;87(4):1926-36. doi: 10.1128/JVI.02903-12. Epub 2012 Dec 5.

19.

West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids.

Martín-Acebes MA, Blázquez AB, Jiménez de Oya N, Escribano-Romero E, Saiz JC.

PLoS One. 2011;6(9):e24970. doi: 10.1371/journal.pone.0024970. Epub 2011 Sep 20.

20.

West Nile virus: A re-emerging pathogen revisited.

Martín-Acebes MA, Saiz JC.

World J Virol. 2012 Apr 12;1(2):51-70. doi: 10.5501/wjv.v1.i2.51. Review.

Supplemental Content

Support Center